Arrhythmias App Update in Conjunction with Android Release of Same

in Medical (E)

[] Taos, New Mexico - Building on the success of the "Arrhythmias" iPhone(R) App, the popular medical application "Arrhythmias" today launched a new version for Android(TM) - Google's open mobile platform - as well as, an updated Universal iDevice (iPod, iPhone, iPad) version.

The flagship app by Abe Balsamo & Co., "Arrhythmias" gets a crucial update. It has been updated with new color scheme, as well as, bug fixes/optimizations for the new Apple iOS software. This comes in the conjunction with the news that "Arrhythmias and Dysrhythmias" has been release for the Android platform, now available in the Google Play Store. The "Arrhythmias" app has been integrated into the world famous AliveCor software, the first ECG for your phone that has passed FDA validation.

A quick reference for medical students, residents and medical professionals, "Arrhythmias" (iDevice) and "Arrhythmias and Dysrhythmias" (Android) aids in the diagnosis of many common and uncommon heart problems. The Apple Store version has been downloaded over 100,000 times and has been named to Apple's "New and Noteworthy" list.

"We are eager to help medical practitioners make quick, informed, peer-reviewed decisions that are in line with the standards of care. We hope to provide affordable ($0.99) peace-of-mind to doctors, PAs, and NPs, as well as EMS professionals, when making decisions at the bedside or even in an ambulance. Our applications help to diagnose and treat very complicated medical problems, such as heart problems," states Abe Balsamo, president of Abe Balsamo & Co.

The apps are inexpensive and high quality, with an intuitive display and easy to use format. There are no "extra clicks," which allows for fast access, needed at the bedside during medical "codes" and life-threatening events. The application is updated regularly and strives to only provide relevant, informative, and even life-saving medical information. This is a very cost effective bedside reference now available for Android and Apple devices.

With the release, Android customers will enjoy the same tools as iPhone users, including:
* Arrhythmias and Dysrhythmias Descriptions
* Representative ECGs
* Peer Reviewed
* Bedside Reference (simple to use interface)
* Award Winning Research
* Treatments (updated regularly)
* No Ads (what?)

Device Requirements:
* iPhone, iPad, and iPod touch
* Requires iOS 7.0 or later
* Universal Application
* 89.6 MB

Pricing and Availability:
Arrhythmias 3.13 is only $0.99 USD (or equivalent amount in other currencies) and available worldwide through the App Store in the Medical category. There is also an Android version available on Google Play. Existing customers who purchased the app will receive a update at no cost. Both platforms are tightly integrated and updated regularly.

Located in Taos, New Mexico, Abe Balsamo & Co. is a small, niche firm intent on providing point-of-care applications for medical providers. This small company has writers, editors, programmers, and doctors on the board of directors. Copyright (C) 2011-2016 Abe Balsamo & Co. All Rights Reserved. Apple, the Apple logo, iPhone, iPod and iPad are registered trademarks of Apple Inc. in the U.S. and/or other countries. Android, Google, Google Play are all registered trademarks of Google Inc in the U.S. and/or other countries.


Twitter: View

Print this page | PDF | TXT | Read other releases by this member.